Jinmao Capital logo

Jinmao Capital

Asia, Beijing, China, Beijing

Description

Jinmao Capital is an investment firm.

Investor Profile

Jinmao Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Seed rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Health Diagnostics, Oncology.

Stage Focus

  • Series C (50%)
  • Seed (50%)

Country Focus

  • China (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Oncology
  • Environmental Engineering
  • Information Technology
  • Infrastructure
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jinmao Capital frequently co-invest with?

Sharewin Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
Haichuanghui Capital
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
Alibaba Health Information Technology
Asia, Beijing, China, Beijing
Co-Investments: 1
Junci Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CCB International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Fortune Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Jinmao Capital?

Sencity

Brooklyn, New York, United States

Sencity designs, owns, and deploys connected infrastructures to make our cities more joyful and livable.

Environmental EngineeringInformation TechnologyInfrastructure
SeedJan 18, 2022
Amount Raised: $1,573,985
Geneplus-Beijing Co. Ltd.

Huakang, Anhui, China

Provider of gene sequencing and detection solutions used in cancer research and treatment.

BiotechnologyHealth DiagnosticsOncology
Series CJul 22, 2021
Amount Raised: $115,907,089